Procurement of Pharmaceutical Medications and Medical Supplies for Indian Army

This tender opportunity, issued by the Department of Military Affairs under the Ministry of Defence, represents a significant requirement for a comprehensive range of pharmaceutical and medical supplies for the Indian Army. With Bid Number GEM/2026/B/8180543, this tender commences on 19-10-2026 at 6:47 PM and concludes on 29-10-2026 at 7:00 PM, providing a focused period for interested parties to submit their proposals. The scope of procurement encompasses a diverse array of medications including, but not limited to, Atorvastatin (10mg and 20mg tablets), Atenolol (50mg tablets), Hematinic tablets/capsules (containing Ferrous Fumarate with elemental Iron and Folic Acid), Azithromycin (500mg tablets), Bisoprolol (2.5mg), Calcium Carbonate with Vitamin D3, Carvedilol (3.125mg), Clonidine (100mcg tablets), Clopidogrel (75mg tablets), combination tablets of Cetirizine, Paracetamol, and Pseudoephedrine, Fluoxetine (20mg), Lamotrigine (25mg dispersible tablets), Metoprolol XL (50mg tablets), Methylcobalamin (1500mcg tablets), Pantoprazole (40mg tablets), Pancreatine (25000IU tablets), Probiotic capsules, Saroglitazer (4mg tablets), Sevlamer (800mg tablets), Sodium Valporate (200mg tablets), Vericiguat (2.5mg tablets), Povidone Iodine Gargle, and Sodium Hyaluronate. Additionally, the tender includes a requirement for a specific medical device, namely an AV Fistula needle (17G). The total quantity sought across all items is 61,330 units. This tender, originating from the Indian Army and managed by the Department of Military Affairs, presents a substantial opportunity for suppliers to contribute to the health and well-being of military personnel through the provision of essential pharmaceutical and medical consumables.